piracetam has been researched along with Agoraphobia in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Agoraphobia: Obsessive, persistent, intense fear of open places.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In an open-label, fixed-flexible dose study, 18 patients with panic disorder with or without agoraphobia (DSM-IV diagnostic criteria) were treated with levetiracetam for 12 weeks." | 9.12 | Safety and efficacy of levetiracetam for patients with panic disorder: results of an open-label, fixed-flexible dose study. ( Papp, LA, 2006) |
| "In an open-label, fixed-flexible dose study, 18 patients with panic disorder with or without agoraphobia (DSM-IV diagnostic criteria) were treated with levetiracetam for 12 weeks." | 5.12 | Safety and efficacy of levetiracetam for patients with panic disorder: results of an open-label, fixed-flexible dose study. ( Papp, LA, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Papp, LA | 1 |
1 trial available for piracetam and Agoraphobia
| Article | Year |
|---|---|
Safety and efficacy of levetiracetam for patients with panic disorder: results of an open-label, fixed-flexible dose study.
Topics: Adolescent; Adult; Agoraphobia; Ambulatory Care; Anticonvulsants; Comorbidity; Diagnostic and Statis | 2006 |